echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > The past and present of rheumatoid arthritis diagnosis and treatment

    The past and present of rheumatoid arthritis diagnosis and treatment

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    To overcome it, you must first understand it


    Rheumatoid arthritis (RA) is an autoimmune disease with erosive joint damage as the main clinical manifestation, which can occur at any age; its basic pathological manifestations are joint synovitis, pannus formation, etc.


    RA does not only affect the joints, but can also be complicated by lung damage, cardiovascular disease, malignant tumors, and depression


    Let's start with the name of RA~

    As early as the 3rd century BC, the word rheumatism (rheuma) appeared in the ancient Greek "Complete Works of Hippocrates", which means "flow", reflecting the initial speculation on the etiology of rheumatism, the famous "humor theory".


    In 1570, the French physician Cuillaume Baillou first used "rheumatism" to name "rheumatism", thinking that rheumatism is a group of independent systemic musculoskeletal diseases


    In 1630, the famous European Renaissance painter Rubens suffered from RA.


    In 1966, the American College of Rheumatology formally named two separate disease types: RA and ankylosing spondylitis (AS)


    Evolution of diagnostic criteria for RA

    The diagnosis of RA mainly depends on clinical manifestations, laboratory and imaging examinations


    Clinically, patients with RA have significant heterogeneity


    Table 1.


    In order to achieve early diagnosis and early treatment of RA to better control the disease, the classification criteria of RA are constantly being updated


    Table 2 RA classification criteria in 2009

    Choice of RA treatment drugs

    Drugs for the treatment of RA mainly fall into the following categories:

    Non-steroidal anti-inflammatory drugs: representative drugs include diclofenac sodium, ibuprofen, meloxicam, celecoxib,


    Glucocorticoids: The application of small doses and short courses of treatment can significantly improve the symptoms of joint swelling and pain, with rapid onset, but cannot block the progression of RA and joint destruction


    Disease-modifying antirheumatic drugs (DMARDs): There are three types of DMARDs, namely traditional synthetic DMARDs (csDMARDs), biological DMARDs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs)


    Epilogue

    As our research on RA continues to deepen, its diagnosis and treatment strategies are also constantly updated, and many innovative drugs have emerged


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.